CN103191305A - Traditional Chinese medicine composition for treating hyperosteogeny - Google Patents
Traditional Chinese medicine composition for treating hyperosteogeny Download PDFInfo
- Publication number
- CN103191305A CN103191305A CN2013100584516A CN201310058451A CN103191305A CN 103191305 A CN103191305 A CN 103191305A CN 2013100584516 A CN2013100584516 A CN 2013100584516A CN 201310058451 A CN201310058451 A CN 201310058451A CN 103191305 A CN103191305 A CN 103191305A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- hyperosteogeny
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating hyperosteogeny. Chinese medicinal raw materials for the composition comprise, by weight, 5 to 25 parts of cortex acanthopanacis, 5 to 25 parts of seatung bark, 5 to 25 parts of Himalayan teasel root, 5 to 25 parts of viscum, 5 to 20 parts of Chinese angelica, 5 to 20 parts of uncaria, 5 to 25 parts of spatholobus stem, 4 to 10 parts of pawpaw, 4 to 10 parts of cassia twig, 4 to 10 parts of notopterygium root, 4 to 10 parts of common bletilla, 5 to 25 parts of speranskia herb, 4 to 10 parts of safflower, 4 to 10 parts of tarragon and 4 to 10 parts of hirsute shiny bugleweed herb. The traditional Chinese medicine composition provided by the invention has effects in promoting blood circulation to remove meridian obstruction, dispelling cold, relieving pain and tonifying liver and kidney, exerts a substantial curative effect and a reliable effect on hyperosteogeny and has the advantages of wide sources of the Chinese medicinal raw materials, easy and convenient preparation, mild action and no toxic and side effects.
Description
Technical field
The present invention relates to a kind of pharmaceutical product of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of hyperosteogeny.
Background technology
Hyperosteogeny is because soft tissue degeneration, degenerations such as the cartilage in formation joint, intervertebral disc, ligaments, the edge, joint forms bony spur, variations such as synovial membrane plumpness, and osteoclasia appears, cause insecondary hyperosteogeny, cause joint deformity, when being subjected to abnormal load, cause arthralgia, a kind of disease of symptoms such as limitation of activity.The method for the treatment of hyperosteogeny has two kinds at present: one, western medicine, the principle of western medicine hyperosteogeny all is antiinflammatory, pain relieving, its medicine commonly used is non-steroid class anti-inflammation analgesic, as ibuprofen, ketoprofen, ibuprofen etc., that is to say, just temporarily alleviate a little miseries, the cause of disease also exists, drug withdrawal still as before, maximum drawback is exactly that the toxic and side effects of taking medicine for a long time is big, the impairing the liver kidney.Two, operative treatment, operative treatment are that the hypertrophy position is removed, and be painful big, is easy to recurrence, and same because the cause of disease also exists, hypertrophy also can regrowth.
The traditional Chinese medical science thinks that hyperosteogeny (bony spur) disease belongs to " arthromyodynia " category of the traditional Chinese medical science, also claims " rheumatism involving the bone ".Hyperosteogeny is relevant with wound, strain, obstruction of collaterals by blood stasis, the damp that is affected by the cold, phlegm resistance, caused by liver and kidney deficiency etc.So suitable blood circulation promoting and blood stasis dispelling
Migratory arthralgia collateral dredging, liver and kidney tonifying.
According to theory of Chinese medical science, at the pathogeny of hyperosteogeny, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
Prior art western medicines in treatment hyperosteogeny is cured the symptoms, not the disease in order to overcome, side effect reaches painful big, the easy deficiency of recurrence of operative treatment hyperosteogeny greatly, the invention provides a kind of prepare easy, cost is low, the Chinese medicine composition of evident in efficacy, the treatment hyperosteogeny that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of hyperosteogeny is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Cortex Acanthopancis 5-25 part, Cortex erythrinae 5-25 part, Radix Dipsaci 5-25 part, parasitic 5-25 part, Radix Angelicae Sinensis 5-20 part, Ramulus Uncariae Cum Uncis 5-20 part, Caulis Spatholobi 5-25 part, Fructus Chaenomelis 4-10 part, Ramulus Cinnamomi 4-10 part, Rhizoma Et Radix Notopterygii 4-10 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 4-10 part, Herba speranskiae tuberculatae 5-25 part, Flos Carthami 4-10 part, Folium Artemisiae Argyi 4-10 part, Herba Lycopi 4-10 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of hyperosteogeny is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 15 parts of Cortex Acanthopanciss, 15 parts of Cortex erythrinaes, 15 parts of Radix Dipsaci, 15 parts of parasitisms, 12 parts of Radix Angelicae Sinensis, 12 parts of Ramulus Uncariae Cum Uncis, 15 parts of Caulis Spatholobis, 6 parts of Fructus Chaenomeliss, 6 parts of Ramulus Cinnamomi, 6 parts of Rhizoma Et Radix Notopterygiis, 6 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 15 parts of Herba speranskiae tuberculataes, 5 parts on Flos Carthami, 5 parts of Folium Artemisiae Argyis, 6 parts of Herba Lycopi.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the Chinese medicine composition of the present invention: Cortex Acanthopancis has the effect of expelling wind and removing dampness, strong muscles and bones, liver and kidney tonifying, promoting blood circulation to remove obstruction in the collateral; Cortex erythrinae has the effect of wind-damp dispelling, channels sootheing and network vessel quickening; Radix Dipsaci has the effect of invigorating the liver and kidney, bone and muscle strengthening, blood circulation regulating; Parasitism has invigorating the liver and kidney, bone and muscle strengthening, except rheumatism, the meridian dredging, beneficial blood, antiabortive effect; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, the effect of menstruction regulating and pain relieving, loosening bowel to relieve constipation; Ramulus Uncariae Cum Uncis has the effect of heat clearing away suppressing the hyperactive liver, relieving spasm by subduing liver-wind; Caulis Spatholobi has to enrich blood invigorates blood circulation, relaxes through the effect of collateral dredging; Fructus Chaenomelis has the effect of suppressing the hyperactive liver Shujin, stomach function regulating removing dampness; Ramulus Cinnamomi has the effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Rhizoma Et Radix Notopterygii has the effect of diffusing exterior cold, wind-damp dispelling, sharp joint, pain relieving; The Pseudobulbus Bletillae (Rhizoma Bletillae) has the effect of removing stasis to stop bleeding, tonifying the lung granulation promoting; Herba speranskiae tuberculatae has the effect of expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation, dissipating blood stasis for subsidence of swelling, detoxifcation ophthalmalgia; Flos Carthami has the effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain; Folium Artemisiae Argyi has warming the meridian for stopping bleeding, dispersing cold for relieving pain, falls the effect of wet parasite killing; The Herba Lycopi has the effect of blood circulation promoting and blood stasis dispelling, line water detumescence.The selected medicament composing prescription of the present invention, its drug component be through dialectical compatibility, complements each other using, and has synergism, plays the effect of promoting blood circulation to remove obstruction in the collateral, dispersing cold for relieving pain, liver and kidney tonifying altogether, and the treatment of hyperosteogeny is reached treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.Various component drug of the present invention adopts decocting soup fumigation and wash method affected part while hot.Through the clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, toxic and side effects do not occur, and effective percentage reaches 93%, cure rate 72%.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of hyperosteogeny, its raw material of Chinese medicine and weight portion proportioning are: Cortex Acanthopancis 15g, Cortex erythrinae 15g, Radix Dipsaci 15g, parasitic 15g, Radix Angelicae Sinensis 12g, Ramulus Uncariae Cum Uncis 12g, Caulis Spatholobi 15g, Fructus Chaenomelis 6g, Ramulus Cinnamomi 6g, Rhizoma Et Radix Notopterygii 6g, Pseudobulbus Bletillae (Rhizoma Bletillae) 6g, Herba speranskiae tuberculatae 15g, Flos Carthami 5g, Folium Artemisiae Argyi 5g, Herba Lycopi 6g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of hyperosteogeny, its raw material of Chinese medicine and weight portion proportioning are: Cortex Acanthopancis 5g, Cortex erythrinae 20g, Radix Dipsaci 10g, parasitic 25g, Radix Angelicae Sinensis 10g, Ramulus Uncariae Cum Uncis 5g, Caulis Spatholobi 25g, Fructus Chaenomelis 10g, Ramulus Cinnamomi 5g, Rhizoma Et Radix Notopterygii 10g, Pseudobulbus Bletillae (Rhizoma Bletillae) 4g, Herba speranskiae tuberculatae 20g, Flos Carthami 8g, Folium Artemisiae Argyi 4g, Herba Lycopi 10g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of hyperosteogeny, its raw material of Chinese medicine and weight portion proportioning are: Cortex Acanthopancis 10g, Cortex erythrinae 25g, Radix Dipsaci 5g, parasitic 10g, Radix Angelicae Sinensis 15g, Ramulus Uncariae Cum Uncis 20g, Caulis Spatholobi 5g, Fructus Chaenomelis 8g, Ramulus Cinnamomi 10g, Rhizoma Et Radix Notopterygii 4g, Pseudobulbus Bletillae (Rhizoma Bletillae) 8g, Herba speranskiae tuberculatae 10g, Flos Carthami 10g, Folium Artemisiae Argyi 8g, Herba Lycopi 5g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of hyperosteogeny, its raw material of Chinese medicine and weight portion proportioning are: Cortex Acanthopancis 25g, Cortex erythrinae 10g, Radix Dipsaci 20g, parasitic 5g, Radix Angelicae Sinensis 20g, Ramulus Uncariae Cum Uncis 10g, Caulis Spatholobi 10g, Fructus Chaenomelis 4g, Ramulus Cinnamomi 8g, Rhizoma Et Radix Notopterygii 5g, Pseudobulbus Bletillae (Rhizoma Bletillae) 10g, Herba speranskiae tuberculatae 5g, Flos Carthami 6g, Folium Artemisiae Argyi 6g, Herba Lycopi 4g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of hyperosteogeny, its raw material of Chinese medicine and weight portion proportioning are: Cortex Acanthopancis 20g, Cortex erythrinae 5g, Radix Dipsaci 25g, parasitic 20g, Radix Angelicae Sinensis 5g, Ramulus Uncariae Cum Uncis 15g, Caulis Spatholobi 20g, Fructus Chaenomelis 5g, Ramulus Cinnamomi 4g, Rhizoma Et Radix Notopterygii 8g, Pseudobulbus Bletillae (Rhizoma Bletillae) 5g, Herba speranskiae tuberculatae 25g, Flos Carthami 4g, Folium Artemisiae Argyi 10g, Herba Lycopi 8g.
Chinese medicine composition in embodiment of the invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15～20 minutes, add water again and do not have about 12 centimetres of powder, decoct.Adopt intense fire to decoct at a simmer, slow fire boiling 20～30 minutes are used in the back of boiling; Second decocts, and adds water and does not have about 10 centimetres of powder, decocts.After boiling, water decocted 15～20 minutes.Decoct extracting juice twice, merge.While hot fumigation and wash method affected part half an hour, wash light and slow exercise joint, back and bend and stretch activity.
A kind of Chinese medicine composition for the treatment of hyperosteogeny, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 100 examples, 25～65 years old age.
Two, usage and dosage: during clinical practice, the amounts of components in the compositions is taken the circumstances into consideration increase and decrease according to patient's body weight and age.Decoct extracting juice for twice, fumigation and wash method affected part half an hour while hot, divide early, evening twice, one pair of medicine used three days, wash light and slow exercise joint, back and bend and stretch activity.
Three, criterion of therapeutical effect:
(1) recovery from illness: patient's pain, bloated, picotement disappearance, joint motion is normal;
(2) produce effects: patient pain, expand, picotement obviously alleviates;
(3) effective: patient's pain, expand, picotement alleviates to some extent;
(4) invalid; Sings and symptoms does not all have obvious improvement, symptom such as preceding.
Four, therapeutic effect: in this clinical observation case, thermal washing 1-2 month, 72 examples of fully recovering were followed up a case by regular visits to and are not seen recurrence; Produce effects 12 examples, effective 9 examples, invalid 7 examples.Toxic and side effects does not take place during the treatment.
Five, model case:
Case 1:
Grandson, woman, 42 years old.Readme: the head and neck shoulder back of the body and numb limbs and tense tendons, twinge, localized pain, tenderness, increase the weight of night.Be diagnosed as hyperosteogeny.With the pharmaceutical treatment of Chinese medicine composition of the present invention preparation 1 month, symptom disappeared substantially, continues treatment 2 months, the symptom complete obiteration.
Case 2:
Sui, the man, 36 years old, the main suit just felt heel pain on foot, beginning pain is not clearly, do not take notice of, but pain was more and more serious afterwards, pain like the pinprick, so check to hospital, check result is hyperosteogeny.With the pharmaceutical treatment of Chinese medicine composition of the present invention preparation 3 months, transference cure was cured fully.
Case 3:
Grandson, man, 58 years old.Two knee joint pain, difficulty in walking, X-ray examination knee joint hyperosteogeny.Pharmaceutical treatment with Chinese medicine composition preparation of the present invention was treated one month, and pain relief continues treatment one month, and pain disappears, and cures fully, followed up a case by regular visits to the nothing recurrence after 1 year.
Claims (2)
1. Chinese medicine composition for the treatment of hyperosteogeny, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Cortex Acanthopancis 5-25 part, Cortex erythrinae 5-25 part, Radix Dipsaci 5-25 part, parasitic 5-25 part, Radix Angelicae Sinensis 5-20 part, Ramulus Uncariae Cum Uncis 5-20 part, Caulis Spatholobi 5-25 part, Fructus Chaenomelis 4-10 part, Ramulus Cinnamomi 4-10 part, Rhizoma Et Radix Notopterygii 4-10 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 4-10 part, Herba speranskiae tuberculatae 5-25 part, Flos Carthami 4-10 part, Folium Artemisiae Argyi 4-10 part, Herba Lycopi 4-10 part.
2. a kind of Chinese medicine composition for the treatment of hyperosteogeny according to claim 1, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 15 parts of Cortex Acanthopanciss, 15 parts of Cortex erythrinaes, 15 parts of Radix Dipsaci, parasitic 15 parts, 12 parts of Radix Angelicae Sinensis, 12 parts of Ramulus Uncariae Cum Uncis, 15 parts of Caulis Spatholobis, 6 parts of Fructus Chaenomeliss, 6 parts of Ramulus Cinnamomi, 6 parts of Rhizoma Et Radix Notopterygiis, 6 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 15 parts of Herba speranskiae tuberculataes, 5 parts on Flos Carthami, 5 parts of Folium Artemisiae Argyis, 6 parts of Herba Lycopi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100584516A CN103191305A (en) | 2013-02-25 | 2013-02-25 | Traditional Chinese medicine composition for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100584516A CN103191305A (en) | 2013-02-25 | 2013-02-25 | Traditional Chinese medicine composition for treating hyperosteogeny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103191305A true CN103191305A (en) | 2013-07-10 |
Family
ID=48714239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100584516A Pending CN103191305A (en) | 2013-02-25 | 2013-02-25 | Traditional Chinese medicine composition for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103191305A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079513A (en) * | 2015-09-25 | 2015-11-25 | 刘连强 | Traditional Chinese medicine composition for treating osteoproliferation |
| CN105943764A (en) * | 2016-06-25 | 2016-09-21 | 丁常燕 | Traditional Chinese medicine composition for treating hyperostosis |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1742830A (en) * | 2005-09-21 | 2006-03-08 | 灵宝市商业医院 | Pain-treating chinese medicine |
| CN1895332A (en) * | 2006-06-05 | 2007-01-17 | 郑少波 | Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production |
| CN101530568A (en) * | 2009-03-25 | 2009-09-16 | 徐理翔 | Paralysis-expelling pain-relieving capsule |
| CN101708321A (en) * | 2009-12-28 | 2010-05-19 | 万小明 | Steaming-washing medicament for treating bone damage disease |
| CN102008648A (en) * | 2010-10-29 | 2011-04-13 | 荣成市新技术应用研究所 | External washing traditional Chinese medicine for treating femoral head necrosis |
| CN102048893A (en) * | 2010-11-24 | 2011-05-11 | 荣成市新技术应用研究所 | Traditional Chinese medicine composition for treating arthromyodynia |
| CN102406723A (en) * | 2011-09-28 | 2012-04-11 | 李军 | Traditional Chinese medicine composition for treating hyperosteogeny |
-
2013
- 2013-02-25 CN CN2013100584516A patent/CN103191305A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1742830A (en) * | 2005-09-21 | 2006-03-08 | 灵宝市商业医院 | Pain-treating chinese medicine |
| CN1895332A (en) * | 2006-06-05 | 2007-01-17 | 郑少波 | Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production |
| CN101530568A (en) * | 2009-03-25 | 2009-09-16 | 徐理翔 | Paralysis-expelling pain-relieving capsule |
| CN101708321A (en) * | 2009-12-28 | 2010-05-19 | 万小明 | Steaming-washing medicament for treating bone damage disease |
| CN102008648A (en) * | 2010-10-29 | 2011-04-13 | 荣成市新技术应用研究所 | External washing traditional Chinese medicine for treating femoral head necrosis |
| CN102048893A (en) * | 2010-11-24 | 2011-05-11 | 荣成市新技术应用研究所 | Traditional Chinese medicine composition for treating arthromyodynia |
| CN102406723A (en) * | 2011-09-28 | 2012-04-11 | 李军 | Traditional Chinese medicine composition for treating hyperosteogeny |
Non-Patent Citations (3)
| Title |
|---|
| 《中外健康文摘》 20110531 王树森 "中西医结合治疗桡骨远端Fernandez分类Ⅲ型骨折" 396-397 第8卷, 第20期 * |
| 彭艳红等: ""中药熏洗治疗软组织损伤120例"", 《中国民间疗法》, vol. 9, no. 9, 30 September 2001 (2001-09-30) * |
| 王树森: ""中西医结合治疗桡骨远端Fernandez分类Ⅲ型骨折"", 《中外健康文摘》, vol. 8, no. 20, 31 May 2011 (2011-05-31), pages 396 - 397 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079513A (en) * | 2015-09-25 | 2015-11-25 | 刘连强 | Traditional Chinese medicine composition for treating osteoproliferation |
| CN105943764A (en) * | 2016-06-25 | 2016-09-21 | 丁常燕 | Traditional Chinese medicine composition for treating hyperostosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327380A (en) | Chinese medicinal composition for treating knee osteoarthritis | |
| CN103463241B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
| CN102920876B (en) | External-application Chinese medicinal composition for treating knee osteoarthritis | |
| CN103316141B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN105560662A (en) | External-use traditional Chinese medicine composition for treating knee osteoarthritis | |
| CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN103028089B (en) | Traditional Chinese medicine composition for treating waist pains of middle-aged and old people | |
| CN103191305A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN103751481A (en) | Oral traditional Chinese medicine for treating heel pain | |
| CN103127458A (en) | Drug for treating osteoarticular myalgia | |
| CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN102784212B (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN105497779A (en) | Traditional Chinese medicine patch for treating acute lumbar sprain | |
| CN105770294A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN104784417A (en) | Traditional Chinese medicine composition for curing impotentia | |
| CN104027451B (en) | A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica | |
| CN103028022B (en) | Traditional Chinese medicine composition for treating arthralgia | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN101204566B (en) | Peroral Chinese traditional medicine composite for hyperosteogeny in knee joint | |
| CN101204533B (en) | Yaotuhuiwei capsule combining anti-walk for prolapse of lumbar intervertebral disc | |
| CN106177775A (en) | A kind of Chinese medicine composition treating hyperosteogeny | |
| CN105079513A (en) | Traditional Chinese medicine composition for treating osteoproliferation | |
| CN105770374A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
| CN104645002A (en) | Traditional Chinese medicine composition for treating deficiency of liver-yin and kidney-yin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130710 |